<akomaNtoso xmlns:uk="https://www.legislation.gov.uk/namespaces/UK-AKN" xmlns:ukl="http://www.legislation.gov.uk/namespaces/legislation" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0" xsi:schemaLocation="http://docs.oasis-open.org/legaldocml/ns/akn/3.0 http://docs.oasis-open.org/legaldocml/akn-core/v1.0/cos01/part2-specs/schemas/akomantoso30.xsd"><act name="uksi"><meta><identification source="#"><FRBRWork><FRBRthis value="http://www.legislation.gov.uk/id/uksi/2011/2159"/><FRBRuri value="http://www.legislation.gov.uk/id/uksi/2011/2159"/><FRBRdate date="2011-08-25" name="made"/><FRBRauthor href="http://www.legislation.gov.uk/id/government/uk"/><FRBRcountry value="GB-UKM"/><FRBRsubtype value="regulation"/><FRBRnumber value="2159"/><FRBRname value="S.I. 2011/2159"/><FRBRprescriptive value="true"/></FRBRWork><FRBRExpression><FRBRthis value="http://www.legislation.gov.uk/uksi/2011/2159/2013-10-01"/><FRBRuri value="http://www.legislation.gov.uk/uksi/2011/2159/2013-10-01"/><FRBRdate date="2013-10-01" name="validFrom"/><FRBRauthor href="#"/><FRBRlanguage language="eng"/></FRBRExpression><FRBRManifestation><FRBRthis value="http://www.legislation.gov.uk/uksi/2011/2159/2013-10-01/data.akn"/><FRBRuri value="http://www.legislation.gov.uk/uksi/2011/2159/2013-10-01/data.akn"/><FRBRdate date="2026-08-27+01:00" name="transform"/><FRBRauthor href="http://www.legislation.gov.uk"/><FRBRformat value="application/akn+xml"/></FRBRManifestation></identification><lifecycle source="#"><eventRef refersTo="#made" date="2011-08-25" eId="date-made" source="#"/><eventRef refersTo="#laid" date="2011-09-07" eId="date-laid-1" source="#united-kingdom-parliament"/><eventRef refersTo="#coming-into-force" date="2011-10-01" eId="date-cif-1" source="#"/><eventRef date="2013-10-01" eId="date-2013-10-01" source="#"/></lifecycle><analysis source="#"><restrictions source="#"><restriction refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#preface" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#body" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#part-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#part-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-10" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-12" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-13" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-14" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-15" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-16" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#part-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-17" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-18" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-19" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-20" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-21" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-22" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-23" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-24" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#part-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-25" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-26" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-27" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#part-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-28" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-29" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-30" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-31" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-32" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-33" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-34" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-35" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-36" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-37" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-38" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-39" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-40" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-41" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-42" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-43" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-44" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-45" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#regulation-46" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#signatures" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedules" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-10" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-12" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-13" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-14" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-15" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-16" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-17" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-18" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-19" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-20" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-21" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-22" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-23" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-24" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-25" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-26" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-27" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-28" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-29" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-30" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-31" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-32" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-33" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-34" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-35" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-36" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-37" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-38" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-39" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-40" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-41" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-42" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-43" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-44" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-45" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-46" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-47" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-48" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-49" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-50" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-51" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-52" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-53" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-54" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-55" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-56" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-57" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-58" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-59" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-60" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-61" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-part-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-62" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-63" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-64" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-65" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-66" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-1-paragraph-67" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-part-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-10" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-12" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-13" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-part-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-14" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-15" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-16" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-17" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-18" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-19" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-part-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-20" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-21" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-22" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-23" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-24" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-part-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-25" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-26" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-27" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-28" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-29" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-part-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-30" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-31" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-32" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-33" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-2-paragraph-34" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-part-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-10" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-12" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-13" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-14" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-15" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-part-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-16" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-17" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-18" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-19" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-20" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-21" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-part-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-22" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-3-paragraph-23" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-4-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-10" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-12" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-13" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-14" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-15" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-16" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-17" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-18" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-19" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-20" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-21" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-22" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-23" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-24" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-25" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-26" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-27" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-28" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-29" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-5-paragraph-30" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-6-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-part-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-1" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-part-2" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-7" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-8" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-9" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-10" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-11" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-12" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-13" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-14" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-15" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-16" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-17" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-18" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-19" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-20" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-21" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-22" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-23" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-24" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-25" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-26" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-part-3" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-27" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-28" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-29" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-30" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-31" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-32" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-33" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-34" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-35" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-36" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-37" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-part-4" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-38" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-39" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-40" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-41" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-part-5" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-42" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-43" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-44" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-part-6" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-45" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-46" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-47" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-48" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-49" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-50" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-51" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-52" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-53" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-54" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-55" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-56" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-57" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-58" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-59" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-60" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-61" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-62" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-63" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#schedule-7-paragraph-64" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction href="#d24e3202" refersTo="#extent-e+w+s+ni" type="jurisdiction"/><restriction refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#preface" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#body" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#part-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#part-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-10" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-11" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-12" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-13" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-14" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-15" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-16" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#part-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-17" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-18" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-19" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-20" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-21" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-22" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-23" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-24" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#part-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-25" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-26" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-27" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#part-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-28" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-29" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-30" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-31" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-32" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-33" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-34" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-35" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-36" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-37" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-38" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-39" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-40" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-41" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-42" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-43" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-44" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-45" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#regulation-46" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#signatures" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedules" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-10" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-11" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-12" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-13" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-14" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-15" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-16" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-17" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-18" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-19" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-20" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-21" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-22" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-23" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-24" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-25" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-26" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-27" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-28" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-29" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-30" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-31" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-32" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-33" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-34" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-35" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-36" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-37" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-38" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-39" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-40" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-41" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-42" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-43" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-44" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-45" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-46" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-47" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-48" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-49" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-50" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-51" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-52" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-53" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-54" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-55" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-56" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-57" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-58" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-59" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-60" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-61" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-part-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-62" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-63" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-64" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-65" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-66" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-1-paragraph-67" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-part-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-10" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-11" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-12" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-13" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-part-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-14" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-15" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-16" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-17" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-18" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-19" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-part-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-20" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-21" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-22" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-23" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-24" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-part-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-25" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-26" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-27" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-28" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-29" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-part-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-30" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-31" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-32" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-33" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-2-paragraph-34" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-part-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-10" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-11" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-12" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-13" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-14" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-15" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-part-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-16" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-17" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-18" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-19" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-20" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-21" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-part-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-22" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-3-paragraph-23" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-4-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-10" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-11" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-12" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-13" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-14" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-15" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-16" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-17" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-18" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-19" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-20" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-21" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-22" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-23" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-24" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-25" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-26" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-27" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-28" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-29" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-5-paragraph-30" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-6-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-part-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-1" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-part-2" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-7" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-8" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-9" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-10" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-11" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-12" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-13" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-14" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-15" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-16" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-17" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-18" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-19" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-20" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-21" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-22" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-23" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-24" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-25" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-26" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-part-3" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-27" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-28" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-29" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-30" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-31" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-32" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-33" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-34" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-35" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-36" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-37" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-part-4" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-38" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-39" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-40" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-41" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-part-5" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-42" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-43" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-44" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-part-6" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-45" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-46" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-47" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-48" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-49" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-50" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-51" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-52" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-53" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-54" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-55" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-56" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-57" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-58" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-59" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-60" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-61" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-62" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-63" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#schedule-7-paragraph-64" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#d24e3202" refersTo="#period-from-2013-10-01" type="jurisdiction"/><restriction href="#d24e3213" refersTo="#period-from-2013-10-01" type="jurisdiction"/></restrictions><otherAnalysis source=""><uk:status href="#preface" refersTo="#status-repealed"/><uk:status href="#body" refersTo="#status-repealed"/><uk:status href="#part-1" refersTo="#status-repealed"/><uk:status href="#regulation-1" refersTo="#status-repealed"/><uk:status href="#regulation-2" refersTo="#status-repealed"/><uk:status href="#regulation-3" refersTo="#status-repealed"/><uk:status href="#part-2" refersTo="#status-repealed"/><uk:status href="#regulation-4" refersTo="#status-repealed"/><uk:status href="#regulation-5" refersTo="#status-repealed"/><uk:status href="#regulation-6" refersTo="#status-repealed"/><uk:status href="#regulation-7" refersTo="#status-repealed"/><uk:status href="#regulation-8" refersTo="#status-repealed"/><uk:status href="#regulation-9" refersTo="#status-repealed"/><uk:status href="#regulation-10" refersTo="#status-repealed"/><uk:status href="#regulation-11" refersTo="#status-repealed"/><uk:status href="#regulation-12" refersTo="#status-repealed"/><uk:status href="#regulation-13" refersTo="#status-repealed"/><uk:status href="#regulation-14" refersTo="#status-repealed"/><uk:status href="#regulation-15" refersTo="#status-repealed"/><uk:status href="#regulation-16" refersTo="#status-repealed"/><uk:status href="#part-3" refersTo="#status-repealed"/><uk:status href="#regulation-17" refersTo="#status-repealed"/><uk:status href="#regulation-18" refersTo="#status-repealed"/><uk:status href="#regulation-19" refersTo="#status-repealed"/><uk:status href="#regulation-20" refersTo="#status-repealed"/><uk:status href="#regulation-21" refersTo="#status-repealed"/><uk:status href="#regulation-22" refersTo="#status-repealed"/><uk:status href="#regulation-23" refersTo="#status-repealed"/><uk:status href="#regulation-24" refersTo="#status-repealed"/><uk:status href="#part-4" refersTo="#status-repealed"/><uk:status href="#regulation-25" refersTo="#status-repealed"/><uk:status href="#regulation-26" refersTo="#status-repealed"/><uk:status href="#regulation-27" refersTo="#status-repealed"/><uk:status href="#part-5" refersTo="#status-repealed"/><uk:status href="#regulation-28" refersTo="#status-repealed"/><uk:status href="#regulation-29" refersTo="#status-repealed"/><uk:status href="#regulation-30" refersTo="#status-repealed"/><uk:status href="#regulation-31" refersTo="#status-repealed"/><uk:status href="#regulation-32" refersTo="#status-repealed"/><uk:status href="#regulation-33" refersTo="#status-repealed"/><uk:status href="#regulation-34" refersTo="#status-repealed"/><uk:status href="#regulation-35" refersTo="#status-repealed"/><uk:status href="#regulation-36" refersTo="#status-repealed"/><uk:status href="#regulation-37" refersTo="#status-repealed"/><uk:status href="#regulation-38" refersTo="#status-repealed"/><uk:status href="#regulation-39" refersTo="#status-repealed"/><uk:status href="#regulation-40" refersTo="#status-repealed"/><uk:status href="#regulation-41" refersTo="#status-repealed"/><uk:status href="#regulation-42" refersTo="#status-repealed"/><uk:status href="#regulation-43" refersTo="#status-repealed"/><uk:status href="#regulation-44" refersTo="#status-repealed"/><uk:status href="#regulation-45" refersTo="#status-repealed"/><uk:status href="#regulation-46" refersTo="#status-repealed"/><uk:status href="#signatures" refersTo="#status-repealed"/><uk:status href="#schedules" refersTo="#status-repealed"/><uk:status href="#schedule-1" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-1" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-2" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-10" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-11" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-12" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-13" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-14" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-15" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-16" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-3" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-17" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-18" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-19" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-20" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-21" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-22" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-23" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-24" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-25" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-26" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-27" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-28" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-29" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-30" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-31" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-32" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-4" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-33" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-34" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-35" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-36" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-37" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-5" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-38" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-39" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-40" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-41" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-6" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-42" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-43" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-44" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-7" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-45" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-46" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-47" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-48" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-49" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-50" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-51" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-52" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-53" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-54" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-8" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-55" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-56" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-57" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-58" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-59" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-60" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-61" refersTo="#status-repealed"/><uk:status href="#schedule-1-part-9" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-62" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-63" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-64" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-65" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-66" refersTo="#status-repealed"/><uk:status href="#schedule-1-paragraph-67" refersTo="#status-repealed"/><uk:status href="#schedule-2" refersTo="#status-repealed"/><uk:status href="#schedule-2-part-1" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-10" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-11" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-12" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-13" refersTo="#status-repealed"/><uk:status href="#schedule-2-part-2" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-14" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-15" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-16" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-17" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-18" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-19" refersTo="#status-repealed"/><uk:status href="#schedule-2-part-3" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-20" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-21" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-22" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-23" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-24" refersTo="#status-repealed"/><uk:status href="#schedule-2-part-4" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-25" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-26" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-27" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-28" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-29" refersTo="#status-repealed"/><uk:status href="#schedule-2-part-5" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-30" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-31" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-32" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-33" refersTo="#status-repealed"/><uk:status href="#schedule-2-paragraph-34" refersTo="#status-repealed"/><uk:status href="#schedule-3" refersTo="#status-repealed"/><uk:status href="#schedule-3-part-1" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-10" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-11" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-12" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-13" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-14" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-15" refersTo="#status-repealed"/><uk:status href="#schedule-3-part-2" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-16" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-17" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-18" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-19" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-20" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-21" refersTo="#status-repealed"/><uk:status href="#schedule-3-part-3" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-22" refersTo="#status-repealed"/><uk:status href="#schedule-3-paragraph-23" refersTo="#status-repealed"/><uk:status href="#schedule-4" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-4-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-5" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-10" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-11" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-12" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-13" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-14" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-15" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-16" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-17" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-18" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-19" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-20" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-21" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-22" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-23" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-24" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-25" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-26" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-27" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-28" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-29" refersTo="#status-repealed"/><uk:status href="#schedule-5-paragraph-30" refersTo="#status-repealed"/><uk:status href="#schedule-6" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-6-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-7" refersTo="#status-repealed"/><uk:status href="#schedule-7-part-1" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-1" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-2" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-3" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-4" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-5" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-6" refersTo="#status-repealed"/><uk:status href="#schedule-7-part-2" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-7" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-8" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-9" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-10" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-11" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-12" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-13" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-14" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-15" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-16" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-17" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-18" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-19" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-20" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-21" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-22" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-23" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-24" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-25" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-26" refersTo="#status-repealed"/><uk:status href="#schedule-7-part-3" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-27" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-28" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-29" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-30" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-31" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-32" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-33" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-34" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-35" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-36" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-37" refersTo="#status-repealed"/><uk:status href="#schedule-7-part-4" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-38" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-39" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-40" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-41" refersTo="#status-repealed"/><uk:status href="#schedule-7-part-5" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-42" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-43" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-44" refersTo="#status-repealed"/><uk:status href="#schedule-7-part-6" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-45" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-46" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-47" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-48" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-49" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-50" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-51" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-52" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-53" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-54" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-55" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-56" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-57" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-58" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-59" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-60" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-61" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-62" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-63" refersTo="#status-repealed"/><uk:status href="#schedule-7-paragraph-64" refersTo="#status-repealed"/><uk:status href="#d24e3202" refersTo="#status-repealed"/><uk:status href="#d24e3213" refersTo="#status-repealed"/><uk:match href="#body" value="false"/><uk:match href="#part-1" value="false"/><uk:match href="#regulation-1" value="false"/><uk:match href="#regulation-2" value="false"/><uk:match href="#regulation-3" value="false"/><uk:match href="#part-2" value="false"/><uk:match href="#regulation-4" value="false"/><uk:match href="#regulation-5" value="false"/><uk:match href="#regulation-6" value="false"/><uk:match href="#regulation-7" value="false"/><uk:match href="#regulation-8" value="false"/><uk:match href="#regulation-9" value="false"/><uk:match href="#regulation-10" value="false"/><uk:match href="#regulation-11" value="false"/><uk:match href="#regulation-12" value="false"/><uk:match href="#regulation-13" value="false"/><uk:match href="#regulation-14" value="false"/><uk:match href="#regulation-15" value="false"/><uk:match href="#regulation-16" value="false"/><uk:match href="#part-3" value="false"/><uk:match href="#regulation-17" value="false"/><uk:match href="#regulation-18" value="false"/><uk:match href="#regulation-19" value="false"/><uk:match href="#regulation-20" value="false"/><uk:match href="#regulation-21" value="false"/><uk:match href="#regulation-22" value="false"/><uk:match href="#regulation-23" value="false"/><uk:match href="#regulation-24" value="false"/><uk:match href="#part-4" value="false"/><uk:match href="#regulation-25" value="false"/><uk:match href="#regulation-26" value="false"/><uk:match href="#regulation-27" value="false"/><uk:match href="#part-5" value="false"/><uk:match href="#regulation-28" value="false"/><uk:match href="#regulation-29" value="false"/><uk:match href="#regulation-30" value="false"/><uk:match href="#regulation-31" value="false"/><uk:match href="#regulation-32" value="false"/><uk:match href="#regulation-33" value="false"/><uk:match href="#regulation-34" value="false"/><uk:match href="#regulation-35" value="false"/><uk:match href="#regulation-36" value="false"/><uk:match href="#regulation-37" value="false"/><uk:match href="#regulation-38" value="false"/><uk:match href="#regulation-39" value="false"/><uk:match href="#regulation-40" value="false"/><uk:match href="#regulation-41" value="false"/><uk:match href="#regulation-42" value="false"/><uk:match href="#regulation-43" value="false"/><uk:match href="#regulation-44" value="false"/><uk:match href="#regulation-45" value="false"/><uk:match href="#regulation-46" value="false"/><uk:match href="#signatures" value="false"/><uk:match href="#schedules" value="false"/><uk:match href="#schedule-1" value="false"/><uk:match href="#schedule-1-part-1" value="false"/><uk:match href="#schedule-1-paragraph-1" value="false"/><uk:match href="#schedule-1-paragraph-2" value="false"/><uk:match href="#schedule-1-paragraph-3" value="false"/><uk:match href="#schedule-1-paragraph-4" value="false"/><uk:match href="#schedule-1-paragraph-5" value="false"/><uk:match href="#schedule-1-part-2" value="false"/><uk:match href="#schedule-1-paragraph-6" value="false"/><uk:match href="#schedule-1-paragraph-7" value="false"/><uk:match href="#schedule-1-paragraph-8" value="false"/><uk:match href="#schedule-1-paragraph-9" value="false"/><uk:match href="#schedule-1-paragraph-10" value="false"/><uk:match href="#schedule-1-paragraph-11" value="false"/><uk:match href="#schedule-1-paragraph-12" value="false"/><uk:match href="#schedule-1-paragraph-13" value="false"/><uk:match href="#schedule-1-paragraph-14" value="false"/><uk:match href="#schedule-1-paragraph-15" value="false"/><uk:match href="#schedule-1-paragraph-16" value="false"/><uk:match href="#schedule-1-part-3" value="false"/><uk:match href="#schedule-1-paragraph-17" value="false"/><uk:match href="#schedule-1-paragraph-18" value="false"/><uk:match href="#schedule-1-paragraph-19" value="false"/><uk:match href="#schedule-1-paragraph-20" value="false"/><uk:match href="#schedule-1-paragraph-21" value="false"/><uk:match href="#schedule-1-paragraph-22" value="false"/><uk:match href="#schedule-1-paragraph-23" value="false"/><uk:match href="#schedule-1-paragraph-24" value="false"/><uk:match href="#schedule-1-paragraph-25" value="false"/><uk:match href="#schedule-1-paragraph-26" value="false"/><uk:match href="#schedule-1-paragraph-27" value="false"/><uk:match href="#schedule-1-paragraph-28" value="false"/><uk:match href="#schedule-1-paragraph-29" value="false"/><uk:match href="#schedule-1-paragraph-30" value="false"/><uk:match href="#schedule-1-paragraph-31" value="false"/><uk:match href="#schedule-1-paragraph-32" value="false"/><uk:match href="#schedule-1-part-4" value="false"/><uk:match href="#schedule-1-paragraph-33" value="false"/><uk:match href="#schedule-1-paragraph-34" value="false"/><uk:match href="#schedule-1-paragraph-35" value="false"/><uk:match href="#schedule-1-paragraph-36" value="false"/><uk:match href="#schedule-1-paragraph-37" value="false"/><uk:match href="#schedule-1-part-5" value="false"/><uk:match href="#schedule-1-paragraph-38" value="false"/><uk:match href="#schedule-1-paragraph-39" value="false"/><uk:match href="#schedule-1-paragraph-40" value="false"/><uk:match href="#schedule-1-paragraph-41" value="false"/><uk:match href="#schedule-1-part-6" value="false"/><uk:match href="#schedule-1-paragraph-42" value="false"/><uk:match href="#schedule-1-paragraph-43" value="false"/><uk:match href="#schedule-1-paragraph-44" value="false"/><uk:match href="#schedule-1-part-7" value="false"/><uk:match href="#schedule-1-paragraph-45" value="false"/><uk:match href="#schedule-1-paragraph-46" value="false"/><uk:match href="#schedule-1-paragraph-47" value="false"/><uk:match href="#schedule-1-paragraph-48" value="false"/><uk:match href="#schedule-1-paragraph-49" value="false"/><uk:match href="#schedule-1-paragraph-50" value="false"/><uk:match href="#schedule-1-paragraph-51" value="false"/><uk:match href="#schedule-1-paragraph-52" value="false"/><uk:match href="#schedule-1-paragraph-53" value="false"/><uk:match href="#schedule-1-paragraph-54" value="false"/><uk:match href="#schedule-1-part-8" value="false"/><uk:match href="#schedule-1-paragraph-55" value="false"/><uk:match href="#schedule-1-paragraph-56" value="false"/><uk:match href="#schedule-1-paragraph-57" value="false"/><uk:match href="#schedule-1-paragraph-58" value="false"/><uk:match href="#schedule-1-paragraph-59" value="false"/><uk:match href="#schedule-1-paragraph-60" value="false"/><uk:match href="#schedule-1-paragraph-61" value="false"/><uk:match href="#schedule-1-part-9" value="false"/><uk:match href="#schedule-1-paragraph-62" value="false"/><uk:match href="#schedule-1-paragraph-63" value="false"/><uk:match href="#schedule-1-paragraph-64" value="false"/><uk:match href="#schedule-1-paragraph-65" value="false"/><uk:match href="#schedule-1-paragraph-66" value="false"/><uk:match href="#schedule-1-paragraph-67" value="false"/><uk:match href="#schedule-2" value="false"/><uk:match href="#schedule-2-part-1" value="false"/><uk:match href="#schedule-2-paragraph-1" value="false"/><uk:match href="#schedule-2-paragraph-2" value="false"/><uk:match href="#schedule-2-paragraph-3" value="false"/><uk:match href="#schedule-2-paragraph-4" value="false"/><uk:match href="#schedule-2-paragraph-5" value="false"/><uk:match href="#schedule-2-paragraph-6" value="false"/><uk:match href="#schedule-2-paragraph-7" value="false"/><uk:match href="#schedule-2-paragraph-8" value="false"/><uk:match href="#schedule-2-paragraph-9" value="false"/><uk:match href="#schedule-2-paragraph-10" value="false"/><uk:match href="#schedule-2-paragraph-11" value="false"/><uk:match href="#schedule-2-paragraph-12" value="false"/><uk:match href="#schedule-2-paragraph-13" value="false"/><uk:match href="#schedule-2-part-2" value="false"/><uk:match href="#schedule-2-paragraph-14" value="false"/><uk:match href="#schedule-2-paragraph-15" value="false"/><uk:match href="#schedule-2-paragraph-16" value="false"/><uk:match href="#schedule-2-paragraph-17" value="false"/><uk:match href="#schedule-2-paragraph-18" value="false"/><uk:match href="#schedule-2-paragraph-19" value="false"/><uk:match href="#schedule-2-part-3" value="false"/><uk:match href="#schedule-2-paragraph-20" value="false"/><uk:match href="#schedule-2-paragraph-21" value="false"/><uk:match href="#schedule-2-paragraph-22" value="false"/><uk:match href="#schedule-2-paragraph-23" value="false"/><uk:match href="#schedule-2-paragraph-24" value="false"/><uk:match href="#schedule-2-part-4" value="false"/><uk:match href="#schedule-2-paragraph-25" value="false"/><uk:match href="#schedule-2-paragraph-26" value="false"/><uk:match href="#schedule-2-paragraph-27" value="false"/><uk:match href="#schedule-2-paragraph-28" value="false"/><uk:match href="#schedule-2-paragraph-29" value="false"/><uk:match href="#schedule-2-part-5" value="false"/><uk:match href="#schedule-2-paragraph-30" value="false"/><uk:match href="#schedule-2-paragraph-31" value="false"/><uk:match href="#schedule-2-paragraph-32" value="false"/><uk:match href="#schedule-2-paragraph-33" value="false"/><uk:match href="#schedule-2-paragraph-34" value="false"/><uk:match href="#schedule-3" value="false"/><uk:match href="#schedule-3-part-1" value="false"/><uk:match href="#schedule-3-paragraph-1" value="false"/><uk:match href="#schedule-3-paragraph-2" value="false"/><uk:match href="#schedule-3-paragraph-3" value="false"/><uk:match href="#schedule-3-paragraph-4" value="false"/><uk:match href="#schedule-3-paragraph-5" value="false"/><uk:match href="#schedule-3-paragraph-6" value="false"/><uk:match href="#schedule-3-paragraph-7" value="false"/><uk:match href="#schedule-3-paragraph-8" value="false"/><uk:match href="#schedule-3-paragraph-9" value="false"/><uk:match href="#schedule-3-paragraph-10" value="false"/><uk:match href="#schedule-3-paragraph-11" value="false"/><uk:match href="#schedule-3-paragraph-12" value="false"/><uk:match href="#schedule-3-paragraph-13" value="false"/><uk:match href="#schedule-3-paragraph-14" value="false"/><uk:match href="#schedule-3-paragraph-15" value="false"/><uk:match href="#schedule-3-part-2" value="false"/><uk:match href="#schedule-3-paragraph-16" value="false"/><uk:match href="#schedule-3-paragraph-17" value="false"/><uk:match href="#schedule-3-paragraph-18" value="false"/><uk:match href="#schedule-3-paragraph-19" value="false"/><uk:match href="#schedule-3-paragraph-20" value="false"/><uk:match href="#schedule-3-paragraph-21" value="false"/><uk:match href="#schedule-3-part-3" value="false"/><uk:match href="#schedule-3-paragraph-22" value="false"/><uk:match href="#schedule-3-paragraph-23" value="false"/><uk:match href="#schedule-4" value="false"/><uk:match href="#schedule-4-paragraph-1" value="false"/><uk:match href="#schedule-4-paragraph-2" value="false"/><uk:match href="#schedule-4-paragraph-3" value="false"/><uk:match href="#schedule-4-paragraph-4" value="false"/><uk:match href="#schedule-4-paragraph-5" value="false"/><uk:match href="#schedule-4-paragraph-6" value="false"/><uk:match href="#schedule-4-paragraph-7" value="false"/><uk:match href="#schedule-4-paragraph-8" value="false"/><uk:match href="#schedule-4-paragraph-9" value="false"/><uk:match href="#schedule-5" value="false"/><uk:match href="#schedule-5-paragraph-1" value="false"/><uk:match href="#schedule-5-paragraph-2" value="false"/><uk:match href="#schedule-5-paragraph-3" value="false"/><uk:match href="#schedule-5-paragraph-4" value="false"/><uk:match href="#schedule-5-paragraph-5" value="false"/><uk:match href="#schedule-5-paragraph-6" value="false"/><uk:match href="#schedule-5-paragraph-7" value="false"/><uk:match href="#schedule-5-paragraph-8" value="false"/><uk:match href="#schedule-5-paragraph-9" value="false"/><uk:match href="#schedule-5-paragraph-10" value="false"/><uk:match href="#schedule-5-paragraph-11" value="false"/><uk:match href="#schedule-5-paragraph-12" value="false"/><uk:match href="#schedule-5-paragraph-13" value="false"/><uk:match href="#schedule-5-paragraph-14" value="false"/><uk:match href="#schedule-5-paragraph-15" value="false"/><uk:match href="#schedule-5-paragraph-16" value="false"/><uk:match href="#schedule-5-paragraph-17" value="false"/><uk:match href="#schedule-5-paragraph-18" value="false"/><uk:match href="#schedule-5-paragraph-19" value="false"/><uk:match href="#schedule-5-paragraph-20" value="false"/><uk:match href="#schedule-5-paragraph-21" value="false"/><uk:match href="#schedule-5-paragraph-22" value="false"/><uk:match href="#schedule-5-paragraph-23" value="false"/><uk:match href="#schedule-5-paragraph-24" value="false"/><uk:match href="#schedule-5-paragraph-25" value="false"/><uk:match href="#schedule-5-paragraph-26" value="false"/><uk:match href="#schedule-5-paragraph-27" value="false"/><uk:match href="#schedule-5-paragraph-28" value="false"/><uk:match href="#schedule-5-paragraph-29" value="false"/><uk:match href="#schedule-5-paragraph-30" value="false"/><uk:match href="#schedule-6" value="false"/><uk:match href="#schedule-6-paragraph-1" value="false"/><uk:match href="#schedule-6-paragraph-2" value="false"/><uk:match href="#schedule-6-paragraph-3" value="false"/><uk:match href="#schedule-6-paragraph-4" value="false"/><uk:match href="#schedule-6-paragraph-5" value="false"/><uk:match href="#schedule-6-paragraph-6" value="false"/><uk:match href="#schedule-6-paragraph-7" value="false"/><uk:match href="#schedule-6-paragraph-8" value="false"/><uk:match href="#schedule-6-paragraph-9" value="false"/><uk:match href="#schedule-7" value="false"/><uk:match href="#schedule-7-part-1" value="false"/><uk:match href="#schedule-7-paragraph-1" value="false"/><uk:match href="#schedule-7-paragraph-2" value="false"/><uk:match href="#schedule-7-paragraph-3" value="false"/><uk:match href="#schedule-7-paragraph-4" value="false"/><uk:match href="#schedule-7-paragraph-5" value="false"/><uk:match href="#schedule-7-paragraph-6" value="false"/><uk:match href="#schedule-7-part-2" value="false"/><uk:match href="#schedule-7-paragraph-7" value="false"/><uk:match href="#schedule-7-paragraph-8" value="false"/><uk:match href="#schedule-7-paragraph-9" value="false"/><uk:match href="#schedule-7-paragraph-10" value="false"/><uk:match href="#schedule-7-paragraph-11" value="false"/><uk:match href="#schedule-7-paragraph-12" value="false"/><uk:match href="#schedule-7-paragraph-13" value="false"/><uk:match href="#schedule-7-paragraph-14" value="false"/><uk:match href="#schedule-7-paragraph-15" value="false"/><uk:match href="#schedule-7-paragraph-16" value="false"/><uk:match href="#schedule-7-paragraph-17" value="false"/><uk:match href="#schedule-7-paragraph-18" value="false"/><uk:match href="#schedule-7-paragraph-19" value="false"/><uk:match href="#schedule-7-paragraph-20" value="false"/><uk:match href="#schedule-7-paragraph-21" value="false"/><uk:match href="#schedule-7-paragraph-22" value="false"/><uk:match href="#schedule-7-paragraph-23" value="false"/><uk:match href="#schedule-7-paragraph-24" value="false"/><uk:match href="#schedule-7-paragraph-25" value="false"/><uk:match href="#schedule-7-paragraph-26" value="false"/><uk:match href="#schedule-7-part-3" value="false"/><uk:match href="#schedule-7-paragraph-27" value="false"/><uk:match href="#schedule-7-paragraph-28" value="false"/><uk:match href="#schedule-7-paragraph-29" value="false"/><uk:match href="#schedule-7-paragraph-30" value="false"/><uk:match href="#schedule-7-paragraph-31" value="false"/><uk:match href="#schedule-7-paragraph-32" value="false"/><uk:match href="#schedule-7-paragraph-33" value="false"/><uk:match href="#schedule-7-paragraph-34" value="false"/><uk:match href="#schedule-7-paragraph-35" value="false"/><uk:match href="#schedule-7-paragraph-36" value="false"/><uk:match href="#schedule-7-paragraph-37" value="false"/><uk:match href="#schedule-7-part-4" value="false"/><uk:match href="#schedule-7-paragraph-38" value="false"/><uk:match href="#schedule-7-paragraph-39" value="false"/><uk:match href="#schedule-7-paragraph-40" value="false"/><uk:match href="#schedule-7-paragraph-41" value="false"/><uk:match href="#schedule-7-part-5" value="false"/><uk:match href="#schedule-7-paragraph-42" value="false"/><uk:match href="#schedule-7-paragraph-43" value="false"/><uk:match href="#schedule-7-paragraph-44" value="false"/><uk:match href="#schedule-7-part-6" value="false"/><uk:match href="#schedule-7-paragraph-45" value="false"/><uk:match href="#schedule-7-paragraph-46" value="false"/><uk:match href="#schedule-7-paragraph-47" value="false"/><uk:match href="#schedule-7-paragraph-48" value="false"/><uk:match href="#schedule-7-paragraph-49" value="false"/><uk:match href="#schedule-7-paragraph-50" value="false"/><uk:match href="#schedule-7-paragraph-51" value="false"/><uk:match href="#schedule-7-paragraph-52" value="false"/><uk:match href="#schedule-7-paragraph-53" value="false"/><uk:match href="#schedule-7-paragraph-54" value="false"/><uk:match href="#schedule-7-paragraph-55" value="false"/><uk:match href="#schedule-7-paragraph-56" value="false"/><uk:match href="#schedule-7-paragraph-57" value="false"/><uk:match href="#schedule-7-paragraph-58" value="false"/><uk:match href="#schedule-7-paragraph-59" value="false"/><uk:match href="#schedule-7-paragraph-60" value="false"/><uk:match href="#schedule-7-paragraph-61" value="false"/><uk:match href="#schedule-7-paragraph-62" value="false"/><uk:match href="#schedule-7-paragraph-63" value="false"/><uk:match href="#schedule-7-paragraph-64" value="false"/><uk:match href="#d24e3202" value="false"/><uk:match href="#d24e3213" value="false"/><uk:commentary href="#act" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#preface" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#part-1" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#part-2" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#part-3" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#part-4" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#part-5" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-1" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-2" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-3" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-4" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-5" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-6" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#schedule-7" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/><uk:commentary href="#d25e3213" refersTo="#key-f7d07e050938f4c588a67c6643bc345c"/></otherAnalysis></analysis><temporalData source="#"><temporalGroup eId="period-from-2013-10-01"><timeInterval start="#date-2013-10-01" refersTo="#"/></temporalGroup></temporalData><references source="#"><TLCOrganization eId="united-kingdom-parliament" href="http://www.legislation.gov.uk/id/" showAs="UnitedKingdomParliament"/><TLCEvent eId="made" href="" showAs="Made"/><TLCEvent eId="laid" href="" showAs="Laid"/><TLCEvent eId="cif" href="" showAs="ComingIntoForce"/><TLCLocation eId="extent-e+w+s+ni" href="/ontology/jurisdictions/uk.EnglandWalesScotlandNorthernIreland" showAs="E+W+S+NI"/><TLCConcept eId="status-repealed" href="" showAs="Repealed"/></references><notes source="#"><note ukl:Name="Commentary" ukl:Type="F" class="commentary F" eId="key-f7d07e050938f4c588a67c6643bc345c" marker="F1"><p>Regulations revoked (1.10.2013) by <ref eId="ciu15exn2-00004" href="http://www.legislation.gov.uk/id/uksi/2013/2033">The Veterinary Medicines Regulations 2013 (S.I. 2013/2033)</ref>, regs. 1, <ref eId="ciu15exn2-00005" class="subref operative" href="http://www.legislation.gov.uk/id/uksi/2013/2033/regulation/47/a">47(a)</ref> (with <ref eId="ciu15exn2-00006" class="subref" href="http://www.legislation.gov.uk/id/uksi/2013/2033/regulation/3">reg. 3</ref>)</p></note><note ukl:Name="Commentary" ukl:Type="F" class="commentary F" eId="key-f7d07e050938f4c588a67c6643bc345c" marker="F2"><p>Regulations revoked (1.10.2013) by <ref eId="ciu15exn2-00004" href="http://www.legislation.gov.uk/id/uksi/2013/2033">The Veterinary Medicines Regulations 2013 (S.I. 2013/2033)</ref>, regs. 1, <ref eId="ciu15exn2-00005" class="subref operative" href="http://www.legislation.gov.uk/id/uksi/2013/2033/regulation/47/a">47(a)</ref> (with <ref eId="ciu15exn2-00006" class="subref" href="http://www.legislation.gov.uk/id/uksi/2013/2033/regulation/3">reg. 3</ref>)</p></note></notes><proprietary xmlns:ukm="http://www.legislation.gov.uk/namespaces/metadata" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" source="#"><dc:identifier>http://www.legislation.gov.uk/uksi/2011/2159</dc:identifier><dc:title>The Veterinary Medicines Regulations 2011 (revoked)</dc:title><dc:subject>Medicines</dc:subject><dc:subject>European Parliament</dc:subject><dc:subject>European Union</dc:subject><dc:subject>Animal health</dc:subject><dc:subject>Animal experimentation</dc:subject><dc:language>en</dc:language><dc:subject scheme="SIheading">MEDICINES</dc:subject><dc:publisher>Statute Law Database</dc:publisher><dc:contributor>Expert Participation</dc:contributor><dc:modified>2024-05-20</dc:modified><dc:contributor>Expert Participation</dc:contributor><dct:valid>2013-10-01</dct:valid><dc:description>These Regulations revoke and remake with amendments the Veterinary Medicines Regulations 2009.</dc:description><ukm:SecondaryMetadata><ukm:DocumentClassification><ukm:DocumentCategory Value="secondary"/><ukm:DocumentMainType Value="UnitedKingdomStatutoryInstrument"/><ukm:DocumentStatus Value="revised"/><ukm:DocumentMinorType Value="regulation"/></ukm:DocumentClassification><ukm:Year Value="2011"/><ukm:Number Value="2159"/><ukm:Made Date="2011-08-25"/><ukm:Laid Date="2011-09-07" Class="UnitedKingdomParliament"/><ukm:ComingIntoForce><ukm:DateTime Date="2011-10-01"/></ukm:ComingIntoForce><ukm:ISBN Value="9780111514924"/></ukm:SecondaryMetadata><ukm:Alternatives><ukm:Alternative URI="http://www.legislation.gov.uk/uksi/2011/2159/pdfs/uksi_20112159_en.pdf" Date="2011-09-13" Size="449894"/></ukm:Alternatives><ukm:Statistics><ukm:TotalParagraphs Value="282"/><ukm:BodyParagraphs Value="46"/><ukm:ScheduleParagraphs Value="236"/><ukm:AttachmentParagraphs Value="0"/><ukm:TotalImages Value="2"/></ukm:Statistics></proprietary></meta><preface eId="preface"><block name="banner">Statutory Instruments</block><block name="number"><docNumber>2011 No. 2159</docNumber></block><container name="subjects"><container name="subject"><block name="subject"><concept refersTo="#">Medicines</concept></block></container></container><block name="title"><docTitle>The Veterinary Medicines Regulations 2011  (revoked)<noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/></docTitle></block><container name="dates"><block name="madeDate" refersTo="#date-made"><span>Made</span><docDate date="2011-08-25">25th August 2011</docDate></block><block name="laidDate" refersTo="#date-laid-1"><span>Laid before Parliament</span><docDate date="2011-09-07">7th September 2011</docDate></block><block name="commenceDate" refersTo="#date-cif-1"><span>Coming into force</span><docDate date="2011-10-01">1st October 2011</docDate></block></container></preface><preamble><formula name="enactingText"><p><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></formula></preamble><body eId="body"><part eId="part-1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 1</num><heading>Introduction</heading><hcontainer name="regulation" eId="regulation-1"><heading>Title and commencement</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-2"><heading>Definition of “veterinary medicinal product”, interpretation and scope</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-3"><heading>Products to which these Regulations do not apply</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer></part><part eId="part-2"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 2</num><heading>Authorised veterinary medicinal products</heading><hcontainer name="regulation" eId="regulation-4"><heading>Placing a veterinary medicinal product on the market</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-5"><heading>Manufacture of veterinary medicinal products</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-6"><heading>The finished product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-7"><heading>Classification, supply and possession of the product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-8"><heading>Administration of the product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-9"><heading>Importation of authorised veterinary medicinal products</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-10"><heading>Advertising the product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>10.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-11"><heading>Advertising of prescription products and products containing psychotropic drugs or narcotics</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>11.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-12"><heading>Defence of publication in the course of business</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>12.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-13"><heading>Wholesale dealing</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>13.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-14"><heading>Feedingstuffs</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>14.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-15"><heading>Exemptions</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>15.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-16"><heading>Fees</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>16.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer></part><part eId="part-3"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 3</num><heading>Records</heading><hcontainer name="regulation" eId="regulation-17"><heading>Food-producing animals: proof of purchase of veterinary medicinal products</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>17.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-18"><heading>Food-producing animals: records of administration by a veterinary surgeon</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>18.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-19"><heading>Food-producing animals: records of acquisition and administration</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>19.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-20"><heading>Food-producing animals: retention of records</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>20.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-21"><heading>Records by a holder of a manufacturing authorisation</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>21.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-22"><heading>Records by a holder of a wholesale dealer’s authorisation</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>22.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-23"><heading>Records of the receipt or supply of prescription products</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>23.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-24"><heading>Records of products administered to a food-producing animal under the cascade</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>24.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer></part><part eId="part-4"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 4</num><heading>Unauthorised veterinary medicinal products</heading><hcontainer name="regulation" eId="regulation-25"><heading>Importation of an unauthorised veterinary medicinal product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>25.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-26"><heading>Possession of an unauthorised veterinary medicinal product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>26.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-27"><heading>Supply of an unauthorised veterinary medicinal product</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>27.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer></part><part eId="part-5"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 5</num><heading>Miscellaneous provisions, enforcement and offences</heading><hcontainer name="regulation" eId="regulation-28"><heading>The Veterinary Products Committee</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>28.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-29"><heading>Veterinary Products Committee appeals procedure</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>29.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-30"><heading>Appeals to an appointed person</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>30.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-31"><heading>Exports</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>31.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-32"><heading>Time limits</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>32.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-33"><heading>Appointment of inspectors</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>33.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-34"><heading>Powers of entry</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>34.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-35"><heading>Powers of an inspector</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>35.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-36"><heading>Inspection of pharmacies</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>36.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-37"><heading>Obstruction</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>37.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-38"><heading>Improvement notices</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>38.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-39"><heading>Appeals against improvement notices</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>39.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-40"><heading>Powers of a court on appeal</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>40.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-41"><heading>Seizure notices</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>41.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-42"><heading>Publication</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>42.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-43"><heading>Penalties</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>43.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-44"><heading>Northern Ireland</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>44.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-45"><heading>Review</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>45.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="regulation" eId="regulation-46"><heading>Revocations</heading><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>46.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer></part><hcontainer name="signatures"><content><p><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></hcontainer><hcontainer name="schedules" eId="schedules"><hcontainer name="schedule" eId="schedule-1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 1<authorialNote class="referenceNote"><p>Regulation 4(3)</p></authorialNote></num><heading>Marketing authorisations</heading><part eId="schedule-1-part-1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 1</num><heading>Application for a marketing authorisation</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e627"><heading>Application for a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e637"><heading>Information with the application</heading><paragraph eId="schedule-1-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e647"><heading>Summary of product characteristics</heading><paragraph eId="schedule-1-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e657"><heading>Supply of a copy of the summary of product characteristics</heading><paragraph eId="schedule-1-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e667"><heading>Time limits for applications for products for use in food-producing animals</heading><paragraph eId="schedule-1-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-2"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 2</num><heading>Derogations from some of the requirements in Part 1</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e683"><heading>Scope</heading><paragraph eId="schedule-1-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e693"><heading>Bibliographic application</heading><paragraph eId="schedule-1-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e703"><heading>Application for a product using a new combination of active substances</heading><paragraph eId="schedule-1-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e713"><heading>Application using existing data</heading><paragraph eId="schedule-1-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e723"><heading>Application for a pharmacologically equivalent medicinal product</heading><paragraph eId="schedule-1-paragraph-10" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>10.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e733"><heading>Time limits for marketing authorisations granted under the procedure for a pharmacologically equivalent product</heading><paragraph eId="schedule-1-paragraph-11" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>11.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e743"><heading>Extension of time limits</heading><paragraph eId="schedule-1-paragraph-12" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>12.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e753"><heading>Parallel imports</heading><paragraph eId="schedule-1-paragraph-13" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>13.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e763"><heading>Specific batch control scheme</heading><paragraph eId="schedule-1-paragraph-14" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>14.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e774"><heading>Similar immunological products</heading><paragraph eId="schedule-1-paragraph-15" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>15.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e784"><heading>Marketing a product authorised in another country</heading><paragraph eId="schedule-1-paragraph-16" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>16.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-3"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 3</num><heading>Grant of a marketing authorisation</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e800"><heading>Time limits</heading><paragraph eId="schedule-1-paragraph-17" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>17.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e810"><heading>Place of establishment of applicant</heading><paragraph eId="schedule-1-paragraph-18" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>18.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e820"><heading>Procedure</heading><paragraph eId="schedule-1-paragraph-19" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>19.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e830"><heading>Products authorised in another Member State</heading><paragraph eId="schedule-1-paragraph-20" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>20.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e840"><heading>Assessment reports</heading><paragraph eId="schedule-1-paragraph-21" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>21.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e850"><heading>Grant of a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-22" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>22.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e860"><heading>Marketing authorisations for food-producing species</heading><paragraph eId="schedule-1-paragraph-23" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>23.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e870"><heading>Refusal of a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-24" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>24.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e880"><heading>Publication following the grant of a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-25" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>25.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e891"><heading>Marketing authorisations in exceptional circumstances</heading><paragraph eId="schedule-1-paragraph-26" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>26.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e901"><heading>Provisions of samples and expertise</heading><paragraph eId="schedule-1-paragraph-27" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>27.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e911"><heading>Supply of information</heading><paragraph eId="schedule-1-paragraph-28" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>28.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e921"><heading>Duties on the holder of a marketing authorisation relating to an immunological product</heading><paragraph eId="schedule-1-paragraph-29" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>29.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e931"><heading>Control tests</heading><paragraph eId="schedule-1-paragraph-30" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>30.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e941"><heading>Placing on the market</heading><paragraph eId="schedule-1-paragraph-31" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>31.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e951"><heading>Duration and validity of a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-32" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>32.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-4"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 4</num><heading>Variations of marketing authorisations on the application of the holder</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e967"><heading>Variation of a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-33" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>33.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e977"><heading>Refusal of a variation of a marketing authorisation</heading><paragraph eId="schedule-1-paragraph-34" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>34.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e987"><heading>Administrative variations</heading><paragraph eId="schedule-1-paragraph-35" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>35.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e997"><heading>Changes after a marketing authorisation has been issued</heading><paragraph eId="schedule-1-paragraph-36" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>36.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1007"><heading>Compulsory variation</heading><paragraph eId="schedule-1-paragraph-37" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>37.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-5"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 5</num><heading>Suspension, <abbr title="et cetera" xml:lang="la">etc.</abbr> of a marketing authorisation</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1026"><heading>Suspension of a marketing authorisation: grounds</heading><paragraph eId="schedule-1-paragraph-38" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>38.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1036"><heading>Suspension of a marketing authorisation: procedure</heading><paragraph eId="schedule-1-paragraph-39" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>39.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1046"><heading>Revocation</heading><paragraph eId="schedule-1-paragraph-40" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>40.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1056"><heading>Prohibiting the supply of veterinary medicinal products</heading><paragraph eId="schedule-1-paragraph-41" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>41.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-6"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 6</num><heading>Mutual recognition and multiple applications</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1072"><heading>Application for a marketing authorisation where one already exists in another member State</heading><paragraph eId="schedule-1-paragraph-42" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>42.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1082"><heading>Application in another Member State</heading><paragraph eId="schedule-1-paragraph-43" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>43.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1092"><heading>Application for a marketing authorisation in multiple Member States where a marketing authorisation does not exist in any member State</heading><paragraph eId="schedule-1-paragraph-44" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>44.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-7"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 7</num><heading>Labelling and package leaflets</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1108"><heading>Approval by the Secretary of State</heading><paragraph eId="schedule-1-paragraph-45" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>45.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1118"><heading>Reference to being authorised</heading><paragraph eId="schedule-1-paragraph-46" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>46.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1128"><heading>Language</heading><paragraph eId="schedule-1-paragraph-47" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>47.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1138"><heading>Labelling with all the information on the immediate packaging</heading><paragraph eId="schedule-1-paragraph-48" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>48.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1148"><heading>Products with immediate and outer packaging</heading><paragraph eId="schedule-1-paragraph-49" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>49.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1158"><heading>Package leaflets</heading><paragraph eId="schedule-1-paragraph-50" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>50.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1168"><heading>Ampoules</heading><paragraph eId="schedule-1-paragraph-51" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>51.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1178"><heading>Small containers other than ampoules</heading><paragraph eId="schedule-1-paragraph-52" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>52.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1188"><heading>Homeopathic remedies</heading><paragraph eId="schedule-1-paragraph-53" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>53.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1199"><heading>Variations</heading><paragraph eId="schedule-1-paragraph-54" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>54.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-8"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 8</num><heading>Pharmacovigilance</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1215"><heading>Qualified persons responsible for pharmacovigilance</heading><paragraph eId="schedule-1-paragraph-55" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>55.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1225"><heading>Duties relating to the qualified person</heading><paragraph eId="schedule-1-paragraph-56" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>56.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1235"><heading>Adverse reactions to a veterinary medicinal product administered in the United Kingdom</heading><paragraph eId="schedule-1-paragraph-57" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>57.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1245"><heading>Adverse reactions to a veterinary medicinal product administered in a third country</heading><paragraph eId="schedule-1-paragraph-58" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>58.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1255"><heading>Periodic safety update reports</heading><paragraph eId="schedule-1-paragraph-59" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>59.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1265"><heading>Release of information by the marketing authorisation holder</heading><paragraph eId="schedule-1-paragraph-60" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>60.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1275"><heading>Action taken on account of pharmacovigilance</heading><paragraph eId="schedule-1-paragraph-61" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>61.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-1-part-9"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 9</num><heading>Homeopathic remedies</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1291"><heading>Meaning of “homeopathic remedy”</heading><paragraph eId="schedule-1-paragraph-62" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>62.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1301"><heading>Placing a homeopathic remedy on the market in accordance with a registration</heading><paragraph eId="schedule-1-paragraph-63" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>63.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1311"><heading>Application for registration</heading><paragraph eId="schedule-1-paragraph-64" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>64.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1321"><heading>Procedure for registration</heading><paragraph eId="schedule-1-paragraph-65" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>65.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1331"><heading>Products on the market before 1994</heading><paragraph eId="schedule-1-paragraph-66" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>66.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1341"><heading>Classification</heading><paragraph eId="schedule-1-paragraph-67" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>67.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part></hcontainer><hcontainer name="schedule" eId="schedule-2"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 2<authorialNote class="referenceNote"><p>Regulation 5(2)</p></authorialNote></num><heading>The manufacture of veterinary medicinal products</heading><part eId="schedule-2-part-1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 1</num><heading>Manufacturing authorisations</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1367"><heading>Application</heading><paragraph eId="schedule-2-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1377"><heading>Time limits</heading><paragraph eId="schedule-2-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1387"><heading>Granting the authorisation</heading><paragraph eId="schedule-2-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1397"><heading>The authorisation</heading><paragraph eId="schedule-2-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1407"><heading>Suspension, variation or revocation of the authorisation</heading><paragraph eId="schedule-2-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1417"><heading>Inspection of premises</heading><paragraph eId="schedule-2-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1427"><heading>Report following inspection</heading><paragraph eId="schedule-2-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1437"><heading>Duties on the holder of a manufacturing authorisation</heading><paragraph eId="schedule-2-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1447"><heading>Qualified persons for manufacture</heading><paragraph eId="schedule-2-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1458"><heading>Refusal or revocation of appointment</heading><paragraph eId="schedule-2-paragraph-10" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>10.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1468"><heading>Duties on a qualified person</heading><paragraph eId="schedule-2-paragraph-11" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>11.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1478"><heading>Register</heading><paragraph eId="schedule-2-paragraph-12" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>12.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1488"><heading>Test sites</heading><paragraph eId="schedule-2-paragraph-13" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>13.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-2-part-2"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 2</num><heading>Authorisation of manufacturers of autogenous vaccines</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1504"><heading>Authorisation to manufacture autogenous vaccines</heading><paragraph eId="schedule-2-paragraph-14" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>14.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1514"><heading>Types of authorisation</heading><paragraph eId="schedule-2-paragraph-15" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>15.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1524"><heading>Labelling</heading><paragraph eId="schedule-2-paragraph-16" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>16.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1534"><heading>Records</heading><paragraph eId="schedule-2-paragraph-17" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>17.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1544"><heading>Adverse reactions</heading><paragraph eId="schedule-2-paragraph-18" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>18.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1554"><heading>Inspection of premises</heading><paragraph eId="schedule-2-paragraph-19" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>19.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-2-part-3"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 3</num><heading>Authorisation of blood banks</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1570"><heading>Authorisation of blood banks</heading><paragraph eId="schedule-2-paragraph-20" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>20.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1580"><heading>Supply and administration of blood from a blood bank</heading><paragraph eId="schedule-2-paragraph-21" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>21.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1590"><heading>Labelling</heading><paragraph eId="schedule-2-paragraph-22" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>22.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1600"><heading>Records</heading><paragraph eId="schedule-2-paragraph-23" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>23.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1610"><heading>Inspection of premises</heading><paragraph eId="schedule-2-paragraph-24" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>24.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-2-part-4"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 4</num><heading>Authorisation of manufacturers of products for administration under the cascade</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1626"><heading>Authorisation to manufacture products for administration under the cascade</heading><paragraph eId="schedule-2-paragraph-25" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>25.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1636"><heading>Labelling</heading><paragraph eId="schedule-2-paragraph-26" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>26.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1646"><heading>Records</heading><paragraph eId="schedule-2-paragraph-27" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>27.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1656"><heading>Adverse reactions</heading><paragraph eId="schedule-2-paragraph-28" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>28.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1666"><heading>Inspection of premises</heading><paragraph eId="schedule-2-paragraph-29" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>29.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-2-part-5"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 5</num><heading>Authorisation of equine stem cell centres</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1682"><heading>Authorisation of stem cell centres</heading><paragraph eId="schedule-2-paragraph-30" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>30.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1692"><heading>Supply and administration of stem cells</heading><paragraph eId="schedule-2-paragraph-31" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>31.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1702"><heading>Labelling</heading><paragraph eId="schedule-2-paragraph-32" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>32.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1712"><heading>Records</heading><paragraph eId="schedule-2-paragraph-33" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>33.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1722"><heading>Inspection of premises</heading><paragraph eId="schedule-2-paragraph-34" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>34.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part></hcontainer><hcontainer name="schedule" eId="schedule-3"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 3<authorialNote class="referenceNote"><p>Regulation 7</p></authorialNote></num><heading>Classification and supply, wholesale dealers and sheep dip</heading><part eId="schedule-3-part-1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 1</num><heading>Classification and supply of authorised veterinary medicinal products</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1748"><heading>Classification of veterinary medicinal products</heading><paragraph eId="schedule-3-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1758"><heading>Wholesale supply of veterinary medicinal products</heading><paragraph eId="schedule-3-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1768"><heading>Retail supply of veterinary medicinal products</heading><paragraph eId="schedule-3-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1778"><heading>Prescriptions by a veterinary surgeon</heading><paragraph eId="schedule-3-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1788"><heading>Prescriptions</heading><paragraph eId="schedule-3-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1798"><heading>Written prescriptions</heading><paragraph eId="schedule-3-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1808"><heading>Duties when a product is prescribed or supplied</heading><paragraph eId="schedule-3-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1818"><heading>Supply by a veterinary surgeon from registered premises</heading><paragraph eId="schedule-3-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1828"><heading>Supply by a veterinary surgeon</heading><paragraph eId="schedule-3-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1839"><heading>Supply by a pharmacist</heading><paragraph eId="schedule-3-paragraph-10" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>10.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1849"><heading>Supply of a veterinary medicinal product for incorporation into feedingstuffs</heading><paragraph eId="schedule-3-paragraph-11" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>11.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1859"><heading>Labelling at the time of retail supply</heading><paragraph eId="schedule-3-paragraph-12" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>12.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1869"><heading>Supply of veterinary medicinal products for use under the cascade</heading><paragraph eId="schedule-3-paragraph-13" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>13.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1879"><heading>Supply by a suitably qualified person</heading><paragraph eId="schedule-3-paragraph-14" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>14.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1889"><heading>Annual audit</heading><paragraph eId="schedule-3-paragraph-15" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>15.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-3-part-2"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 2</num><heading>Requirements for a wholesale dealer’s authorisation</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1905"><heading>Application</heading><paragraph eId="schedule-3-paragraph-16" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>16.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1915"><heading>Time limits</heading><paragraph eId="schedule-3-paragraph-17" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>17.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1925"><heading>Granting the authorisation</heading><paragraph eId="schedule-3-paragraph-18" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>18.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1935"><heading>The authorisation</heading><paragraph eId="schedule-3-paragraph-19" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>19.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1945"><heading>Suspension, variation or revocation of the authorisation</heading><paragraph eId="schedule-3-paragraph-20" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>20.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1955"><heading>Duties on the holder of a wholesale dealer’s authorisation</heading><paragraph eId="schedule-3-paragraph-21" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>21.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-3-part-3"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 3</num><heading>Sheep dip</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e1971"><heading>Supply of sheep dip</heading><paragraph eId="schedule-3-paragraph-22" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>22.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e1981"><heading>Use of sheep dip</heading><paragraph eId="schedule-3-paragraph-23" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>23.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part></hcontainer><hcontainer name="schedule" eId="schedule-4"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 4<authorialNote class="referenceNote"><p>Regulation 8</p></authorialNote></num><heading>Administration of a veterinary medicinal product outside the terms of a marketing authorisation</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2001"><heading>Administration under the cascade</heading><paragraph eId="schedule-4-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2011"><heading>Withdrawal periods</heading><paragraph eId="schedule-4-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2021"><heading>Administration to food-producing horses</heading><paragraph eId="schedule-4-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2031"><heading>Immunological products for serious epizootic disease</heading><paragraph eId="schedule-4-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2041"><heading>Immunological products for an imported or exported animal</heading><paragraph eId="schedule-4-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2051"><heading>Administration by veterinary surgeons from other Member States</heading><paragraph eId="schedule-4-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2061"><heading>Treatment in exceptional circumstances</heading><paragraph eId="schedule-4-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2071"><heading>Administration of a homeopathic remedy</heading><paragraph eId="schedule-4-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2081"><heading>Administration under an animal test certificate</heading><paragraph eId="schedule-4-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></hcontainer><hcontainer name="schedule" eId="schedule-5"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 5<authorialNote class="referenceNote"><p>Regulation 14</p></authorialNote></num><heading>Medicated feedingstuffs and specified feed additives</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2101"><heading>Scope and interpretation</heading><paragraph eId="schedule-5-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2111"><heading>Enforcement of Regulation <ref eId="c00052" href="http://www.legislation.gov.uk/european/regulation/2002/0178">(EC) No 178/2002</ref></heading><paragraph eId="schedule-5-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2123"><heading>Enforcement of Regulation <ref eId="c00054" href="http://www.legislation.gov.uk/european/regulation/2003/1831">(EC) No 1831/2003</ref></heading><paragraph eId="schedule-5-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2135"><heading>Enforcement of Regulation <ref eId="c00057" href="http://www.legislation.gov.uk/european/regulation/2004/0882">(EC) No 882/2004</ref></heading><paragraph eId="schedule-5-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2147"><heading>Enforcement of Regulation <ref eId="c00059" href="http://www.legislation.gov.uk/european/regulation/2005/0183">(EC) No 183/2005</ref></heading><paragraph eId="schedule-5-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2159"><heading>Enforcement of Regulation <ref eId="c00061" href="http://www.legislation.gov.uk/european/regulation/2009/0767">(EC) No 767/2009</ref></heading><paragraph eId="schedule-5-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2171"><heading>Approval of manufacturers and distributors of feedingstuffs containing veterinary medicinal products</heading><paragraph eId="schedule-5-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2181"><heading>Incorporation of a veterinary medicinal product into a premixture</heading><paragraph eId="schedule-5-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2191"><heading>Top dressing</heading><paragraph eId="schedule-5-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2201"><heading>Incorporation of a veterinary medicinal product into feedingstuffs</heading><paragraph eId="schedule-5-paragraph-10" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>10.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2211"><heading>Additional record keeping requirements relating to veterinary medicinal products</heading><paragraph eId="schedule-5-paragraph-11" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>11.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2222"><heading>Labelling a premixture containing a veterinary medicinal product</heading><paragraph eId="schedule-5-paragraph-12" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>12.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2232"><heading>Labelling of feedingstuffs containing a specified feed additive</heading><paragraph eId="schedule-5-paragraph-13" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>13.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2242"><heading>Labelling of feedingstuffs containing a veterinary medicinal product</heading><paragraph eId="schedule-5-paragraph-14" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>14.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2252"><heading>Supply of specified feed additives</heading><paragraph eId="schedule-5-paragraph-15" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>15.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2262"><heading>Supply of premixture</heading><paragraph eId="schedule-5-paragraph-16" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>16.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2272"><heading>Supply of a complementary feedingstuff</heading><paragraph eId="schedule-5-paragraph-17" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>17.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2282"><heading>Supply of feedingstuffs containing a veterinary medicinal product</heading><paragraph eId="schedule-5-paragraph-18" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>18.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2292"><heading>Prescriptions for feedingstuffs containing a veterinary medicinal product</heading><paragraph eId="schedule-5-paragraph-19" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>19.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2302"><heading>Writing the prescription</heading><paragraph eId="schedule-5-paragraph-20" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>20.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2312"><heading>Possession</heading><paragraph eId="schedule-5-paragraph-21" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>21.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2322"><heading>Sampling and analysis</heading><paragraph eId="schedule-5-paragraph-22" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>22.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2333"><heading>Storage</heading><paragraph eId="schedule-5-paragraph-23" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>23.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2343"><heading>Packages and other containers</heading><paragraph eId="schedule-5-paragraph-24" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>24.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2353"><heading>Transport</heading><paragraph eId="schedule-5-paragraph-25" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>25.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2363"><heading>Possession, placing on the market and use of feedingstuffs</heading><paragraph eId="schedule-5-paragraph-26" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>26.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2373"><heading>Imports from third countries</heading><paragraph eId="schedule-5-paragraph-27" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>27.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2383"><heading>Trade between Member States</heading><paragraph eId="schedule-5-paragraph-28" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>28.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2393"><heading>Import for incorporation into premixture or feedingstuffs for export</heading><paragraph eId="schedule-5-paragraph-29" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>29.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2403"><heading>Animals on domestic premises</heading><paragraph eId="schedule-5-paragraph-30" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>30.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></hcontainer><hcontainer name="schedule" eId="schedule-6"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 6<authorialNote class="referenceNote"><p>Regulation 15(4)</p></authorialNote></num><heading>Exemptions for small pet animals</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2423"><heading>Animals to which this Schedule applies</heading><paragraph eId="schedule-6-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2433"><heading>Placing on the market, importing and administering the product</heading><paragraph eId="schedule-6-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2443"><heading>Manufacture</heading><paragraph eId="schedule-6-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2453"><heading>Approval of the active substance</heading><paragraph eId="schedule-6-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2463"><heading>The product</heading><paragraph eId="schedule-6-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2473"><heading>Labelling</heading><paragraph eId="schedule-6-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2483"><heading>Administration</heading><paragraph eId="schedule-6-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2493"><heading>Pack size</heading><paragraph eId="schedule-6-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2503"><heading>Adverse reactions</heading><paragraph eId="schedule-6-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></hcontainer><hcontainer name="schedule" eId="schedule-7"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>SCHEDULE 7<authorialNote class="referenceNote"><p>Regulation 16</p></authorialNote></num><heading>Fees</heading><part eId="schedule-7-part-1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 1</num><heading>Introduction</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2529"><heading>Interpretation</heading><paragraph eId="schedule-7-paragraph-1" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>1.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2539"><heading>Payment of fees</heading><paragraph eId="schedule-7-paragraph-2" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>2.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2549"><heading>Time of payment</heading><paragraph eId="schedule-7-paragraph-3" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>3.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2559"><heading>Multiple inspections</heading><paragraph eId="schedule-7-paragraph-4" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>4.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2569"><heading>Expenses for inspections outside the United Kingdom</heading><paragraph eId="schedule-7-paragraph-5" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>5.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2579"><heading>Translation</heading><paragraph eId="schedule-7-paragraph-6" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>6.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-7-part-2"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 2</num><heading>Fees relating to marketing authorisations</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2595"><heading>Fees for specified pharmaceutical applications</heading><paragraph eId="schedule-7-paragraph-7" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>7.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2605"><heading>Decentralised pharmaceutical application where the United Kingdom is the reference Member State</heading><paragraph eId="schedule-7-paragraph-8" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>8.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2615"><heading>Application for a marketing authorisation for an immunological product</heading><paragraph eId="schedule-7-paragraph-9" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>9.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2625"><heading>Decentralised immunological application where the United Kingdom is the reference Member State</heading><paragraph eId="schedule-7-paragraph-10" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>10.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2635"><heading>Application for a marketing authorisation using identical data</heading><paragraph eId="schedule-7-paragraph-11" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>11.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2645"><heading>Application for an exceptional marketing authorisation (pharmaceutical)</heading><paragraph eId="schedule-7-paragraph-12" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>12.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2655"><heading>Fees for an application for an exceptional marketing authorisation (immunological)</heading><paragraph eId="schedule-7-paragraph-13" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>13.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2665"><heading>Fee for the conversion from an exceptional to a full marketing authorisation</heading><paragraph eId="schedule-7-paragraph-14" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>14.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2675"><heading>Application for a marketing authorisation relating to a parallel import</heading><paragraph eId="schedule-7-paragraph-15" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>15.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2686"><heading>Application to change the distribution category of a product authorised through the centralised procedure</heading><paragraph eId="schedule-7-paragraph-16" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>16.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2696"><heading>Application for a variation to a marketing authorisation dealt with under national or mutual recognition variation procedures.</heading><paragraph eId="schedule-7-paragraph-17" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>17.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2706"><heading>Application for a variation to a marketing authorisation dealt with under worksharing procedures</heading><paragraph eId="schedule-7-paragraph-18" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>18.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2716"><heading>Application for an extension dealt with under the decentralised procedure where the United Kingdom is the reference Member State</heading><paragraph eId="schedule-7-paragraph-19" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>19.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2726"><heading>Provision of information relating to the recognition of a United Kingdom marketing authorisation or an extension</heading><paragraph eId="schedule-7-paragraph-20" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>20.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2736"><heading>Exception for a variation relating to animal testing</heading><paragraph eId="schedule-7-paragraph-21" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>21.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2746"><heading>Application for the renewal of a national marketing authorisation</heading><paragraph eId="schedule-7-paragraph-22" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>22.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2756"><heading>Application for the renewal of a marketing authorisation obtained through mutual recognition or the decentralised procedure</heading><paragraph eId="schedule-7-paragraph-23" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>23.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2766"><heading>Registration of a homeopathic remedy</heading><paragraph eId="schedule-7-paragraph-24" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>24.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2776"><heading>Annual fees for marketing authorisations</heading><paragraph eId="schedule-7-paragraph-25" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>25.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2786"><heading>Auditor’s certificate</heading><paragraph eId="schedule-7-paragraph-26" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>26.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-7-part-3"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 3</num><heading>Fees payable by manufacturers</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2802"><heading>Application for a manufacturing authorisation</heading><paragraph eId="schedule-7-paragraph-27" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>27.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2812"><heading>Application for a variation of a manufacturing authorisation</heading><paragraph eId="schedule-7-paragraph-28" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>28.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2822"><heading>Application for an authorisation to manufacture an autogenous vaccine or a product for administration under the cascade</heading><paragraph eId="schedule-7-paragraph-29" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>29.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2832"><heading>Annual fees</heading><paragraph eId="schedule-7-paragraph-30" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>30.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2842"><heading>Site inspections – type of site</heading><paragraph eId="schedule-7-paragraph-31" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>31.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2852"><heading>Inspection of a site where immunological veterinary medicinal products are manufactured</heading><paragraph eId="schedule-7-paragraph-32" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>32.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2862"><heading>Inspection of a site where sterile veterinary medicinal products are manufactured</heading><paragraph eId="schedule-7-paragraph-33" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>33.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2872"><heading>Inspection of a site where no immunological or sterile veterinary medicinal products are manufactured</heading><paragraph eId="schedule-7-paragraph-34" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>34.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2882"><heading>Inspection of a site where veterinary medicinal products are assembled</heading><paragraph eId="schedule-7-paragraph-35" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>35.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2893"><heading>Test sites</heading><paragraph eId="schedule-7-paragraph-36" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>36.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2903"><heading>Animal blood bank or equine stem cell centre authorisations</heading><paragraph eId="schedule-7-paragraph-37" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>37.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-7-part-4"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 4</num><heading>Fees relating to a wholesale dealer’s authorisation</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2919"><heading>Application for a wholesale dealer’s authorisation</heading><paragraph eId="schedule-7-paragraph-38" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>38.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2929"><heading>Variation of a wholesale dealer’s authorisation</heading><paragraph eId="schedule-7-paragraph-39" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>39.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2939"><heading>Annual fee for a wholesale dealer’s authorisation</heading><paragraph eId="schedule-7-paragraph-40" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>40.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2949"><heading>Inspection of a wholesale dealer’s premises</heading><paragraph eId="schedule-7-paragraph-41" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>41.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-7-part-5"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 5</num><heading>Fees relating to feedingstuffs</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e2965"><heading>Fees relating to feedingstuffs</heading><paragraph eId="schedule-7-paragraph-42" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>42.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2975"><heading>Fees relating to premises for supply by suitably qualified persons</heading><paragraph eId="schedule-7-paragraph-43" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>43.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e2985"><heading>Reduced fees</heading><paragraph eId="schedule-7-paragraph-44" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>44.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part><part eId="schedule-7-part-6"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>PART 6</num><heading>General</heading><hcontainer name="crossheading" class="schGroup7" eId="d25e3001"><heading>Testing samples</heading><paragraph eId="schedule-7-paragraph-45" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>45.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3011"><heading>Animal test certificates</heading><paragraph eId="schedule-7-paragraph-46" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>46.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3021"><heading>Importation of a veterinary medicinal product for treatment under the cascade</heading><paragraph eId="schedule-7-paragraph-47" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>47.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3031"><heading>Importation of a veterinary medicinal product for administration under the Animals (Scientific Procedures) Act 1986</heading><paragraph eId="schedule-7-paragraph-48" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>48.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3041"><heading>Wholesale dealer’s import certificate</heading><paragraph eId="schedule-7-paragraph-49" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>49.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3051"><heading>Specific batch control</heading><paragraph eId="schedule-7-paragraph-50" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>50.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3061"><heading>Submission of control tests of an immunological product</heading><paragraph eId="schedule-7-paragraph-51" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>51.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3071"><heading>Export certificates</heading><paragraph eId="schedule-7-paragraph-52" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>52.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3081"><heading>Provision of advice</heading><paragraph eId="schedule-7-paragraph-53" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>53.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3092"><heading>Appeals to the Veterinary Products Committee: marketing authorisations and animal test certificates</heading><paragraph eId="schedule-7-paragraph-54" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>54.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3102"><heading>Appeals to the Veterinary Products Committee: variations</heading><paragraph eId="schedule-7-paragraph-55" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>55.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3112"><heading>Appeal to the Veterinary Products Committee: suspensions</heading><paragraph eId="schedule-7-paragraph-56" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>56.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3122"><heading>Appeal to the Veterinary Products Committee: active substance under Schedule 6</heading><paragraph eId="schedule-7-paragraph-57" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>57.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3132"><heading>Fee relating to an appointed person</heading><paragraph eId="schedule-7-paragraph-58" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>58.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3142"><heading>Fees relating to a veterinary surgeon’s practice premises</heading><paragraph eId="schedule-7-paragraph-59" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>59.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3152"><heading>Refund of fees relating to the Veterinary Products Committee or appointed persons</heading><paragraph eId="schedule-7-paragraph-60" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>60.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3162"><heading>Fees relating to an improvement notice</heading><paragraph eId="schedule-7-paragraph-61" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>61.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3172"><heading>Non-payment of fees</heading><paragraph eId="schedule-7-paragraph-62" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>62.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3182"><heading>Waiver or reduction of fees</heading><paragraph eId="schedule-7-paragraph-63" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>63.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer><hcontainer name="crossheading" class="schGroup7" eId="d25e3192"><heading>Reduction of fees when an application is withdrawn</heading><paragraph eId="schedule-7-paragraph-64" class="schProv1"><num><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>64.</num><content><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></content></paragraph></hcontainer></part></hcontainer></hcontainer></body><conclusions><blockContainer class="explanatoryNote"><heading><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>EXPLANATORY NOTE</heading><subheading>(This note is not part of the Regulations)</subheading><blockContainer ukl:Name="P"><p>These Regulations revoke and remake with amendments the Veterinary Medicines Regulations 2009.</p></blockContainer><blockContainer ukl:Name="P1group"><heading><noteRef href="#key-f7d07e050938f4c588a67c6643bc345c" uk:name="commentary" ukl:Name="CommentaryRef" class="commentary"/>Principal changes to the 2009 Regulations:</heading><blockContainer ukl:Name="P"><p>. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .</p></blockContainer></blockContainer><blockContainer ukl:Name="P"><p>A full impact assessment has been prepared and placed in the libraries of both Houses of Parliament. It is available, together with a transposition note and a table showing fee changes, on 
<a href="http://www.vmd.defra.gov.uk">www.vmd.defra.gov.uk</a> at “Publications, Veterinary Medicines Regulations and Guidance”.</p></blockContainer></blockContainer></conclusions></act></akomaNtoso>